Regional Dengue Symposium Addresses Today’s Challenges in Dengue Control

RIO DE JANEIRO, BRAZIL — November 3, 2015 — More than one hundred public health experts and stakeholders gathered today in Rio de Janeiro, Brazil, for the First Regional Dengue Symposium, led by the Pan American Health Organization (PAHO), the Sabin Vaccine Institute (Sabin) and the Dengue Vaccine Initiative (DVI).
11.03.15 to 11.04.15
Rio de Janeiro, Brazil

On October 13, Mike McQuestion, Director of Sabin’s Sustainable Immunization Financing (SIF) program, spoke to officials in the parliament in Tbilisi, Georgia, lauding the country’s impressive performance on immunization and calling for other countries to follow its example.

During the month of October, END7 student supporters are celebrating NTD Success Stories — spreading the exciting news that many countries around the world have already made incredible progress towards the control and elimination of some NTDs. In recent weeks, there have been many new successes to celebrate.
Dr. Sazaly has been involved with dengue research for over 20 years and has also maintained strong research interest in emerging infectious diseases. His interest in dengue, in particular, is rooted in its knowledge gaps: “it is a fascinating disease needing a lot more research to take on.” In an interview with DVI, Dr. Sazaly shares more on his views of dengue prevention and control and needs in the dengue research field.